FDA Inspection
Texas Health Presbyterian Hospital of Dallas Blood BankTexas Health Presbyterian Hospital of Dallas Blood Bank – FDA Inspection, May 24, 2024
Record Details
This FDA Inspection record concerns Texas Health Presbyterian Hospital of Dallas Blood Bank, with an inspection on May 24, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 24, 2024
- Product Type
- Biologics
View Company Profile
ID · f5417669-5b20-4aaf-88fd-5fbd244bf295
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1240230
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Texas Health Presbyterian Hospital of Dallas Blood Bank
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 27, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 15, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 9, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Texas Health Presbyterian Hospital of Dallas Blood Bank
- FDA Inspection 1067153 - 2018-09-12
- FDA Inspection 985514 - 2016-08-09
- FDA Inspection 871807 - 2014-03-27
- FDA Inspection 772306 - 2012-03-15
- FDA Inspection 649028 - 2010-02-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.